Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018)
Baxter International's (BAX) quarterly Non-Current Deferred Tax Liability came in at $205.0 million in Q4 2018, down 26.79% year-on-year from $280.0 million in Q4 2017, and down 26.79% on a QoQ basis from $280.0 million in Q4 2017.
Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018) Analysis & Trends
Baxter International (BAX) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $205.0 million in Q4 2018.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 26.79% year-over-year to $205.0 million in Q4 2018; TTM through Dec 2018 was $205.0 million, a 26.79% decrease from a year earlier, with the FY2018 full-year figure at $205.0 million, down 26.79% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2018 stood at $205.0 million, down from $280.0 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for BAX reached as high as $280.0 million in Q4 2017 and fell as low as $52.0 million in Q1 2015.
- Historically, Non-Current Deferred Tax Liability has averaged $165.5 million across 5 years, with a median of $181.5 million in 2014.
- Across the five-year window, Non-Current Deferred Tax Liability plunged 52.31% in 2016 and surged 201.08% in 2017, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $168.0 million in 2014, then gained by 16.07% to $195.0 million in 2015, then tumbled by 52.31% to $93.0 million in 2016, then jumped by 201.08% to $280.0 million in 2017, then retreated by 26.79% to $205.0 million in 2018.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $205.0 million in Q4 2018, $280.0 million in Q4 2017, and $93.0 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Mar 31, 2015 | 52.00 Mn |
| Mar 31, 2015 | 52.00 Mn |
| Dec 31, 2014 | 168.00 Mn |
| Dec 31, 2014 | 168.00 Mn |